UTI Stock Analysis: Buy, Sell, or Hold?
UTI - Universal Technical Institute, Inc.
$19.38
0.35 (1.84%)
▲
5d:
-4.53%
30d:
-7.36%
90d:
-61.19%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 18, 2026
Get Alerted When UTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: UTI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: UTI shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.44
Based on 12.9% avg growth
INTRINSIC VALUE TODAY
$20.77
6.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UTI is currently trading at $19.38, which is considered oversold relative to its 30-day fair value range of $19.69 to $21.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 26.4) compared to its historical average (38.2). Remarkably, the market is currently pricing in an annual earnings decline of 11.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, UTI is in a strong downtrend. Immediate support is located at $18.02, while resistance sits at $21.37.
Market Sentiment: UTI scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.83 (+100.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, UTI is in a strong downtrend. Immediate support is located at $18.02, while resistance sits at $21.37.
Market Sentiment: UTI scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.83 (+100.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.69 -
$21.77
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding UTI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.4% below Wall St target ($38.83)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.69 -
$21.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.02
Resistance Level
$21.37
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.37
Wall Street Target
$38.83
(+100.4%)
Revenue Growth (YoY)
7.2%
Earnings Growth (YoY)
-78.9%
Profit Margin
3.9%
Valuation Discount vs History
-11.6% cheaper
PE vs Historical
26.4 vs 38.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.6%
(market-implied from PE analysis)
1-Year Target
$17.44
(-10%)
2-Year Target
$15.70
(-19%)
3-Year Target
$14.13
(-27%)
3-Yr Target (if PE normalizes)
(PE: 26→38)
$20.47
(+6%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.4, Growth: 21.8%)
$35.04
(+81%)
Base:
(SPY PE: 20.4, Growth: 21.8%)
$27.11
(+40%)
Bear:
(PE: 17.3, Growth: 21.8%)
$23.05
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 30.69 | Current EPS (TTM): $0.62
Bull Case
$24.82
(+28%)
Analyst growth 18.5%, PE expands to 33.8
Base Case
$22.56
(+16%)
Market implied 18.5%, PE stable at 30.7
Bear Case
$12.94
(-33%)
Severe decline -20.0%, PE contracts to 26.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 26.4 to 38.2
Stabilization Target:
$28.08
(+44.9%)
PE Expansion Potential:
+44.9%
Share & Embed Analysis
Last updated: October 03, 2026 1:11 AM ET
Data refreshes hourly during market hours. Next update: 2:11 AM
Data refreshes hourly during market hours. Next update: 2:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Education & Training Services Stocks
Top-rated stocks in Education & Training Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EDU
New Oriental Education &… |
BUY
23 analysts |
$74 | 65 BUY |
|
TAL
TAL Education Group |
STRONG BUY
19 analysts |
$16 | 51 HOLD |
|
COUR
Coursera Inc |
BUY
15 analysts |
$8 | 71 BUY |
|
KLC
KinderCare Learning Comp… |
STRONG BUY
8 analysts |
$4 | 48 HOLD |
|
LRN
Stride Inc |
STRONG BUY
6 analysts |
$109 | 59 HOLD |
Advanced UTI Option Strategies
Professional options setups generated by AI based on today's UTI price and gamma walls.
